Logos Global Management LP Kiniksa Pharmaceuticals, Ltd. Transaction History

Logos Global Management LP

  • $756 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$14.37 - $19.07 $2.16 Million - $2.86 Million
150,000 New
150,000 $2.63 Million
Q3 2021

Nov 15, 2021
SELL
$11.39 - $16.23 $9.11 Million - $13 Million
-800,000 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$13.22 - $19.09 $5.29 Million - $7.64 Million
400,000 Added 100.0%
800,000 $11.1 Million
Q1 2021

May 17, 2021
BUY
$16.68 - $23.97 $6.67 Million - $9.59 Million
400,000 New
400,000 $7.4 Million

Others Institutions Holding KNSA

# of Institutions
8
Shares Held
1.95M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $687M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email